US Patent Issued to Icahn School of Medicine at Mount Sinai on Nov. 4 for "Implantable device and method of brain biomodulation" (New York Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,458,813, issued on Nov. 4, was assigned to Icahn School of Medicine at Mount Sinai (New York).

"Implantable device and method of brain biomodulation" was invented by Alexis Bruhat (New York), Turner Baker (New York), Christopher Kellner (New York) and Anthony Costa (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "An intracranial photobiomodulation system (IPS) comprises a removeable light therapy implant and a permanent sheath. The removeable light therapy implant is adapted to be removably secured to the sheath and has (i) a support arm having a proximal end and a distal end, and (ii) at least one light source located along the support arm. The ...